All clinical trials come with inherent challenges. Sponsors must navigate an intricate web of regulatory issues, approval time frames,  operational complexities, and perhaps the greatest hurdle – patient recruitment and retention. These predictable challenges are compounded exponentially in global clinical trials due to their scope. Jeffery Zucker, Worldwide, discusses how global clinical trials can quickly spiral out of control, and the best practices to avoid this.